Table 3.
Kaplan-Meier | Cox Regression Analysis | |||
---|---|---|---|---|
Significance | Significance | Exp(B) | CI | |
VCAMa | ||||
<1272 ng/ml | <0.001** | 0.001** | 1 | |
1272-1972 ng/ml | 1.7 | 0.83, 3.51 | ||
>1972 ng/ml | 3.3 | 1.7, 6.4 | ||
VCAMb | ||||
<1272 ng/ml | <0.001** | 0.030* | 1 | |
1272-1972 ng/ml | 1.5 | 0.73, 3.16 | ||
>1972 ng/ml | 2.4 | 1.21, 4.81 | ||
VCAMc | ||||
<1272 ng/ml | <0.001** | 0.049* | 1 | |
1272-1972 ng/ml | 1.4 | 0.6, 2.9 | ||
>1972 ng/ml | 2.2 | 1.1, 4.5 |
Levels of significance (* p < 0.05, ** p < 0.01).
aCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol and HDL cholesterol.
bCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR and hsCRP.
cCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR, hsCRP and history of vascular disease at enrolment